Personal information

Activities

Works (3)

Cost-effectiveness of pertuzumab and trastuzumab biosimilar combination therapy as initial treatment for HER2-positive metastatic breast cancer in Singapore

Expert Review of Pharmacoeconomics & Outcomes Research
2021-05-04 | Journal article
Contributors: Li-Jen Cheng; Lydia Loke; Elaine Hsuen Lim; Fiona Pearce; Mohamed Ismail Abdul Aziz; Kwong Ng
Source: check_circle
Crossref

Cost‐effectiveness of ribociclib as initial treatment for premenopausal women with advanced breast cancer in Singapore

Cancer Reports
2021-02 | Journal article
Contributors: Lydia Loke; Soo‐Chin Lee; Fiona Pearce; Kwong Ng; Mohamed Ismail Abdul Aziz
Source: check_circle
Crossref

Cost-effectiveness analysis of pembrolizumab monotherapy versus chemotherapy for previously untreated advanced non-small cell lung cancer

Journal of Medical Economics
2020-09-01 | Journal article
Contributors: Mohamed Ismail Abdul Aziz; Ling Eng Tan; Wan Hui Gloria Tan; Chee-Keong Toh; Lydia Pui Yee Loke; Fiona Pearce; Kwong Ng
Source: check_circle
Crossref